[Proceedings: Tryptophan hydroxylase inhibition as therapy for carcinoid tumors].
D002275:Carcinoid Heart Disease / Q000209:etiology; D002276:Carcinoid Tumor / Q000188:drug therapy*; D003248:Constipation / Q000139:chemically induced; D003967:Diarrhea / Q000209:etiology; D004802:Eosinophilia / Q000139:chemically induced; D010134:Fenclonine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D008113:Liver Neoplasms; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D009362:Neoplasm Metastasis; D014365:Tryptophan Hydroxylase / Q000037:antagonists & inhibitors*
D006897:Hydroxyindoleacetic Acid; D006899:Mixed Function Oxygenases; D014365:Tryptophan Hydroxylase; D010134:Fenclonine
Therapeutische Studien über die Hemmung der Tryptophan-Hydroxylase beim Carcinoid